NO850399L - Fremgangsmaate for fremstilling av 6-substituerte furo (3,4-c)pyridin-derivater - Google Patents

Fremgangsmaate for fremstilling av 6-substituerte furo (3,4-c)pyridin-derivater

Info

Publication number
NO850399L
NO850399L NO850399A NO850399A NO850399L NO 850399 L NO850399 L NO 850399L NO 850399 A NO850399 A NO 850399A NO 850399 A NO850399 A NO 850399A NO 850399 L NO850399 L NO 850399L
Authority
NO
Norway
Prior art keywords
procedure
preparation
pyridine derivatives
substituted furo
furo
Prior art date
Application number
NO850399A
Other languages
English (en)
Other versions
NO160369C (no
NO160369B (no
Inventor
Andre Esanu
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of NO850399L publication Critical patent/NO850399L/no
Publication of NO160369B publication Critical patent/NO160369B/no
Publication of NO160369C publication Critical patent/NO160369C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
NO850399A 1984-02-02 1985-02-01 Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive 1,3-dihydro-6-(1-hydroksy-2-dimetylaminometyl-allyl)-7-hydroksy-furo(3,4-c)-pyridinderivater. NO160369C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848402740A GB8402740D0 (en) 1984-02-02 1984-02-02 Furo-(3 4-c)-pyridine derivatives

Publications (3)

Publication Number Publication Date
NO850399L true NO850399L (no) 1985-08-05
NO160369B NO160369B (no) 1989-01-02
NO160369C NO160369C (no) 1989-04-12

Family

ID=10555953

Family Applications (1)

Application Number Title Priority Date Filing Date
NO850399A NO160369C (no) 1984-02-02 1985-02-01 Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive 1,3-dihydro-6-(1-hydroksy-2-dimetylaminometyl-allyl)-7-hydroksy-furo(3,4-c)-pyridinderivater.

Country Status (24)

Country Link
US (1) US4581362A (no)
JP (1) JPS60181088A (no)
AT (1) AT391700B (no)
BE (1) BE901545A (no)
CA (1) CA1300148C (no)
CH (1) CH663023A5 (no)
DE (1) DE3503435A1 (no)
DK (1) DK158951C (no)
DZ (1) DZ743A1 (no)
ES (1) ES8607308A1 (no)
FI (1) FI82051C (no)
FR (2) FR2559062B1 (no)
GB (1) GB8402740D0 (no)
HK (1) HK92587A (no)
IE (1) IE58229B1 (no)
IT (1) IT1200587B (no)
LU (1) LU85744A1 (no)
MA (1) MA20342A1 (no)
NL (1) NL8500241A (no)
NO (1) NO160369C (no)
OA (1) OA07947A (no)
PT (1) PT79913B (no)
SE (2) SE460903B (no)
ZA (1) ZA85508B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
JPH054664A (ja) * 1991-06-21 1993-01-14 Yoozuri:Kk 運搬等用の包装体及び包装方法
EP2797597B1 (en) 2011-12-28 2020-02-26 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
LT3141542T (lt) 2011-12-28 2020-09-25 Global Blood Therapeutics, Inc. Pakeistieji benzaldehido junginiai ir jų panaudojimas didinant audinių aprūpinimą deguonimi
SG10201802911RA (en) 2013-03-15 2018-05-30 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
SG11201507349TA (en) 2013-03-15 2015-10-29 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
WO2014145040A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
PE20160078A1 (es) 2013-03-15 2016-03-02 Global Blood Therapeutics Inc Compuestos y sus usos para modular la hemoglobina
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
SG10201804139VA (en) 2014-02-07 2018-06-28 Global Blood Therapeutics Inc Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
MX2018006832A (es) 2015-12-04 2018-11-09 Global Blood Therapeutics Inc Regimenes de dosificacion de 2-hidroxi-6-((2-(1-isopropil-1h-piraz ol-5-il)-piridin-3-il)-metoxi)-benzaldehido.
TWI825524B (zh) 2016-05-12 2023-12-11 美商全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
ES2966707T3 (es) 2018-10-01 2024-04-23 Global Blood Therapeutics Inc Moduladores de la hemoglobina para el tratamiento de la drepanocitosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
IN156817B (no) * 1981-02-10 1985-11-09 Scras
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives

Also Published As

Publication number Publication date
FR2559062A1 (fr) 1985-08-09
DE3503435A1 (de) 1985-08-08
BE901545A (fr) 1985-07-22
MA20342A1 (fr) 1985-10-01
SE8500460L (sv) 1985-08-03
SE8500460D0 (sv) 1985-02-01
LU85744A1 (fr) 1985-07-24
AT391700B (de) 1990-11-12
ES8607308A1 (es) 1986-05-16
FI850275L (fi) 1985-08-03
JPH0240069B2 (no) 1990-09-10
DK158951C (da) 1990-12-31
IE58229B1 (en) 1993-08-11
ATA27585A (de) 1990-05-15
DE3503435C2 (no) 1991-11-07
NO160369C (no) 1989-04-12
FR2559152B1 (fr) 1987-05-22
SE460903B (sv) 1989-12-04
GB8402740D0 (en) 1984-03-07
DK158951B (da) 1990-08-06
OA07947A (fr) 1987-01-31
FI82051B (fi) 1990-09-28
US4581362A (en) 1986-04-08
FI850275A0 (fi) 1985-01-22
IT8519327A0 (it) 1985-02-01
DZ743A1 (fr) 2004-09-13
ZA85508B (en) 1985-11-27
CH663023A5 (fr) 1987-11-13
DK45585D0 (da) 1985-02-01
DK45585A (da) 1985-08-03
FI82051C (fi) 1991-01-10
FR2559062B1 (fr) 1987-05-22
FR2559152A1 (fr) 1985-08-09
NO160369B (no) 1989-01-02
HK92587A (en) 1987-12-11
CA1300148C (en) 1992-05-05
IT1200587B (it) 1989-01-27
ES540080A0 (es) 1986-05-16
PT79913A (en) 1985-03-01
JPS60181088A (ja) 1985-09-14
IE850241L (en) 1985-08-02
PT79913B (en) 1986-11-10
NL8500241A (nl) 1985-09-02

Similar Documents

Publication Publication Date Title
NO850399L (no) Fremgangsmaate for fremstilling av 6-substituerte furo (3,4-c)pyridin-derivater
NO820253L (no) Fremgangsmaate for fremstilling av furo-(3,4-c)pyridin-derivater
NO841322L (no) Fremgangsmaate for fremstilling av furo (3,4-c)-pyridin-derivater
NO874764L (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
AU3800785A (en) Pyrazolo(4,3-b)pyridine derivatives
ES537665A0 (es) Procedimiento para preparar derivados de 1, 3-dihidro-6-vinil-7-hidroxifuro-(3, 4-c)-piridina
NO171914C (no) Analogifremgangsmaate ved fremstilling av tricykliske pyridinderivate
NO180308C (no) Fremgangsmåte for fremstilling av en tilnærmet ikke-racemisk form av furo (3,4-c) pyridin-derivater
NO851920L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO881333D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinderivater
NO845038L (no) Fremgangsmaate for fremstilling av 4,5,6,7-tetrahydrotiazolo(5,4-c)pyridin-derivater
ES536814A0 (es) Procedimiento de preparacion de nuevos derivados de 1, 3-dihidro-6-metil-7-hidroxi-furo-(3, 4-c)-piridina
NO854206L (no) Fremgangsmaate for fremstilling av dioksino-(4,5-c)-pyridinderivater.
NO854277L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 6-fenetylaminoalkyl-7-hydroksy-furo-(3,4-c)-pyridin-derivater.
NO853418L (no) Fremgangsmaate for fremstilling av 6-(1-hydroksy-2-dimetylaminometyl-allyl)-furo(3,4-c) pyridin-derivater.
GR860368B (en) Process for the preparation of pyridine derivatives
NO852563L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater.
NO853475L (no) Fremgangsmaate for fremstilling av nye 6-aminometyl-furo (3,4-c) pyridin-derivater.
GB8907480D0 (en) Separation of insomers of furo(3,4-c)pyridine derivatives
ES541910A0 (es) Procedimiento para la fabricacion de derivados de 4,7-dihi- dropirazolo (3,4-b)piridina
AU576906B2 (en) 2-phenylpyrano(2,3-b) pyridine derivatives
NO851319L (no) Fremgangsmaate for fremstilling av eburnanderivater.
DK177790D0 (da) Furo(3,4-c)pyridinderivater
IE843199L (en) Substituted spiro pyridine derivatives
PL263015A1 (en) The method of manufacture of derivatives of 6-h-indol/2,3-b/-quinoline